Cite
HARVARD Citation
Mody, R. et al. (2019). Adherence, persistence, glycaemic control and costs among patients with type 2 diabetes initiating dulaglutide compared with liraglutide or exenatide once weekly at 12‐month follow‐up in a real‐world setting in the United States. Diabetes, obesity & metabolism. 21 (4), pp. 920-929. [Online].